PRELUDE THERAPEUTICS INC Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PRELUDE THERAPEUTICS INC stock issued during period, value, new issues for the quarter ending 2023-06-30 was $110.42M.
- PRELUDE THERAPEUTICS INC stock issued during period, value, new issues for the quarter ending 2021-03-31 was $161.41M.
- PRELUDE THERAPEUTICS INC stock issued during period, value, new issues for the quarter ending 2020-09-30 was $166.63M.
- PRELUDE THERAPEUTICS INC stock issued during period, value, new issues for fiscal 2025 was $24.64M.
- PRELUDE THERAPEUTICS INC stock issued during period, value, new issues for fiscal 2023 was $135.29M.
- PRELUDE THERAPEUTICS INC stock issued during period, value, new issues for fiscal 2021 was $161.41M, a 3.13% decline from fiscal 2020.
- PRELUDE THERAPEUTICS INC stock issued during period, value, new issues for fiscal 2020 was $166.63M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $24.64M 10-K · filed 2026-03-10 | |
| 2023-12-31 | $135.29M 10-K · filed 2025-03-10 | |
| 2023-06-30 | $110.42M 10-Q · filed 2024-11-06 | |
| 2021-12-31 | $161.41M 10-K · filed 2023-03-15 | |
| 2021-03-31 | $161.41M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $166.63M 10-K · filed 2022-03-17 | |
| 2020-09-30 | $166.63M 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |